Skip to content

The Postoperative Lidocaine and Ketamine Effects on Morphine Requirement in Bariatric Surgery

Post-operative Morphine Consumption in Obese Patients Undergoing Laparoscopic Bariatric Surgery Following Ketamina and Lidocaine Perfusion

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05591105
Enrollment
64
Registered
2022-10-24
Start date
2023-06-15
Completion date
2024-01-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia Morbidity, Obesity, Morbid, Opioid Use, Pharmacological Action, Post Operative Pain

Brief summary

The goal of this observational study is to evaluate the quality of postoperative analgesia in a group of obese patients schedule to bariatric surgery under TIVA Opiod-free after to receive lidocaine and ketamine perfusion. The main question it aims to answer are: How lidocaine and ketamine perfusion during recovery period does impact over morphine consumption on the following 48 hours after surgery? All participants will receive total intravenous anesthesia and, at the end of the surgery, they will be divided in two groups, group A: placebo and, group B: with postoperative lidocaine and ketamine perfusion. Our hypothesis is ketamine and lidocaine are a good alternative to decrease the use of morphine in obese patients.

Detailed description

The obese patients have more risk for certain side effects and complications with elevated risk of perioperative mortality and morbidity. An effective postoperative pain management is important to prevent pulmonary complications and, it is not recommended continuous infusions of opioids in this kind of patients, because the opioid-induced upper airway obstruction and respiratory depression are more likely to be seen in obese patients with obstructive sleep apnea. We can reduce perioperative opioid using dexmedetomidine, ketamine and lidocaine, however, it is a little know the use and benefits of lidocaine and ketamine inmediately after surgery.

Interventions

DRUGControl Group

At the end of surgery, they will continue receiving analgesia according the schedule and, addicionally, lidocaine (1 mg/kg/h) and Ketamine (0,15 mg/kg/h) for 90 minute as part of postoperative analgesia.

DRUGPlacebo

At the end of surgery, they will continue receiving analgesia according the schedule.

Sponsors

Tiva Group
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* All patients between 18 y 65 years old. * IMC \> 30 kg/m2 * ASA II/III

Exclusion criteria

* Patients taking high doses of opioids before operation for chronic pain * Patients with allergies to any study medication. * Pregnancy or breastfeeding. * Kidney or heptic failure. * Surgical complication

Design outcomes

Primary

MeasureTime frameDescription
Postoperative morphine consumption48 hoursThe visual analog scale (VAS) will be used to measure pain on recovery room and hospitalization area.

Other

MeasureTime frameDescription
Kind of surgeryDuring surgeryThe laparoscopic Sleeve Gastrectomy is technically more simple and shorter surgery time than the Roux-en-Y Gastric Bypass and maybe less painfull

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026